Essential for processes requiring sterility assurance! The filter integrity testing device compliant with data integrity demonstrates highly reliable performance.
The Palltronic® Flowstar V is a filter integrity testing device that meets the latest regulatory requirements and can perform reliable integrity tests in the filtration sterilization processes of pharmaceutical manufacturing, where sterility assurance is necessary. Developed based on years of experience and extensive expertise, it retains the features of the previous model while being even more user-friendly, with enhanced data integrity and quality risk management functions. [Compliance with Data Integrity and 21 CFR Part 11 Requirements] It is equipped with performance that complies with guidelines on data integrity and electronic signature security from 21 CFR Part 11 and the UK Medicines and Healthcare products Regulatory Agency (MHRA), addressing each requirement. Therefore, it demonstrates reliable performance in the filtration sterilization processes of pharmaceutical manufacturing, where sterility assurance is required.
Inquire About This Product
basic information
**Main Features of Palltronic Flowstar V** ■ Highest level of data integrity support and testing accuracy ■ More advanced automation options and easy network integration ■ Features that support enhanced quality risk management For more details, please contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 Guarantee of filtration sterilization in critical processes of pharmaceutical manufacturing. 【Track Record】 There are thousands of installations worldwide. Please contact us for more details.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.